Dr. Yong-Sung Kim, PhD

Professor, Department of Molecular Science and Technology at Ajou University

Speaker

Dr. Yong-Sung Kim has been a professor in the Dept. of Molecular Science and Technology at Ajou University (Suwon, Korea) since 2004. Dr. Kim obtained his M.Sc. in Biotechnology in 1998 from KAIST (Daejon, Korea) and Ph.D. in Pharmaceutical Sciences in 2002 from the University of Colorado, USA. He did a post-doc in Prof. K. Dane Wittrup’s lab at MIT. He also spent one year (2010-2011) during his Sabbatical at Genentech Inc. (SF, USA).

Dr. Kim’s research focuses on the development of therapeutic antibody platform technology, including heterodimeric Fc-based bispecific antibodies and immunocytokines, and cytosol-penetrating antibodies. Dr. Kim has published more than 120 articles in peer-reviewed scientific journals and filed/obtained numerous domestic and international patents (≥ 100 patents). Dr. Kim co-founded Orum Therapeutics Inc. in 2016 and Pinetree Therapeutics Inc. (Boston, USA) in 2019. In addition, Dr. Kim has transferred 5 antibody-related technologies to companies in Korea and USA. His website is http://antibody.ajou.ac.kr/.